White Paper
AI in Life Sciences Commercialization
Strategic insights and practical recommendations from 2025 survey of commercial leaders
Aug 19, 2025
Download

Artificial intelligence (AI) is no longer experimental, it’s essential to commercial success in life sciences. In this new white paper, IQVIA shares findings from a 2025 survey of commercial leaders, revealing how organizations are moving from AI ambition to enterprise-scale execution.

Discover how companies are embedding AI across functions, achieving 2X–3X ROI, and overcoming barriers. With strategic insights and a practical playbook for scaling AI, this report is a must-read for leaders looking to turn innovation into impact.

Turn AI Ambition into Commercial Advantage
Connect with IQVIA experts to explore how AI can enhance decision-making, improve performance, and drive impact across your commercial strategy

Related solutions

Contact Us